Summary
This Nature Reviews Endocrinology article by Karamitri and Jockers synthesises evidence on melatonin's physiological roles in glucose metabolism and energy homeostasis, as suggested by the 2018 literature. The review appears to examine mechanistic pathways through which melatonin dysregulation may contribute to type 2 diabetes and obesity, particularly via circadian and mitochondrial mechanisms. The authors likely discuss therapeutic implications and potential interventions targeting melatonin signalling in these metabolic conditions.
UK applicability
Findings on melatonin's metabolic role may inform UK dietary and clinical approaches to type 2 diabetes prevention and management, though the review's primary focus is mechanistic rather than food-system interventions. UK public health policy on circadian health and sleep quality in relation to metabolic disease risk could potentially benefit from this endocrinological synthesis.
Key measures
Melatonin concentration; glucose tolerance; insulin secretion; adipose tissue markers; circadian rhythm parameters; metabolic outcomes in type 2 diabetes and obesity
Outcomes reported
The review examined melatonin's mechanisms of action in type 2 diabetes mellitus and obesity, synthesising evidence on metabolic and endocrine pathways. It considered melatonin's effects on glucose homeostasis, insulin secretion, adipose tissue function, and circadian regulation as they relate to these metabolic disorders.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.